The potential involvement of HGF/Met in Src/ezrin-mediated tumour angio/lymphangiogenesis is consistent with our recent finding demonstrating Src/ezrin co-operation increased Met activation and extracellular matrix degradation, characteristic of an invasive phenotype in breast cancer [44]. The gene discussed is SRC; the disease is breast carcinoma.